UPDATE 1-Cellcom sees better 2012 after Q4 profit sinks
* Q4 net profit falls 76 pct to 76 mln shekels
* Co had forecast outcome of 70-80 mln
* Revenue up 0.2 pct to 1.67 bln shekels
* To pay dividend of 0.72 shekels a share
(Adds details, CEO comment)
JERUSALEM, March 7 (Reuters) - Cellcom , Israel's largest mobile phone operator, reported a 76 percent drop in quarterly profit on Wednesday but predicted an improvement in 2012 due to its acquisition of internet service provider Netvision.
Cellcom posted fourth-quarter net income of 76 million shekels ($20 million), down from 319 million a year earlier. It had warned in January that net profit in the final three months of 2011 would be between 70 million shekels and 80 million.
Cellcom and rivals Partner and Bezeq unit Pelephone were hit in 2011 by a steep reduction in the fees mobile operators charge each other to connect calls and the elimination of exit fines for customers.
A lawsuit by customers and a deferred tax expense also weighed on Cellcom's results in the quarter. Cellcom is appealing against the court order that it should repay customers charges it implemented for providing call detail records, having previously provided them free.
Revenue increased by 0.2 percent to 1.67 billion shekels, while earnings before interest, taxes, depreciation and amortisation slid 32.6 percent to 425 million.
Cellcom said it had consolidated Netvision's results starting in the fourth quarter.
Nir Sztern, Cellcom's chief executive, said the company's main goals in 2012 were to cut costs by creating efficiencies and to continue upgrading its network to allow for surfing speeds of up to 84 megabits per second.
"We estimate that we will see the synergies of the merger (with Netvision) both in terms of income and expenses during 2012 and the following years," Sztern said.
"In 2012 and the upcoming years we will deepen our focus on cellular internet growth by continuing to introduce data devices, such as (for) tablets and smartphones," Sztern said.
Its subscriber base fell by 1.3 percent in 2011 to 3.349 million. Some 40 percent were customers of its third-generation (3G) network.
Cellcom said it would pay a quarterly dividend of 72 million shekels, or 0.72 shekels a share. Dividends in 2011 totaled 785 million shekels.
(Reporting by Steven Scheer; Editing by David Holmes)
((steven.scheer@thomsonreuters.com)(+972 2 632 2210)(Reuters Messaging: steven.scheer.thomsonreuters.com@reuters.net))
Recent CEL News
- Celadon Pharmaceuticals confirms future payments amid funding delays • Alliance News • 08/23/2024 10:51:28 AM
- Celadon Pharmaceuticals PLC Update on Financial Position • RNS Regulatory News • 08/23/2024 06:00:06 AM
- Celadon Pharmaceutical shares dive amid delayed receipt of funds • Alliance News • 08/12/2024 08:59:11 AM
- Celadon Pharmaceuticals PLC Update on Operations and Financial Position • RNS Regulatory News • 08/12/2024 06:00:06 AM
- Gateley earnings fall; 4Global revenue rises • Alliance News • 07/16/2024 06:25:24 PM
- Celadon Pharmaceuticals PLC Successful Completion of Eighth Harvest of 2024 • RNS Regulatory News • 07/16/2024 06:00:07 AM
- Celadon Pharmaceuticals PLC Third Admission of Shares • RNS Regulatory News • 07/15/2024 12:58:13 PM
- Celadon Pharmaceuticals PLC Result of AGM • RNS Regulatory News • 06/28/2024 06:00:12 AM
- Celadon Pharmaceuticals PLC Second Admission of Shares • RNS Regulatory News • 06/07/2024 06:00:09 AM
- No Headline Available • Alliance News • 06/03/2024 05:01:12 PM
- Celadon Pharmaceuticals PLC Publication of Annual Report & Notice of AGM • RNS Regulatory News • 06/03/2024 04:45:01 PM
- Celadon ships to US; Oxford BioDynamics-Goodbody pact • Alliance News • 05/23/2024 08:08:53 PM
- Celadon Pharmaceuticals PLC Supply of Products to New US Customer • RNS Regulatory News • 05/23/2024 06:00:13 AM
- Celadon Pharmaceuticals PLC Exercise of Share Options and Total Voting Rights • RNS Regulatory News • 05/15/2024 01:45:01 PM
- Headlam warns of loss; EnSilica predicts revenue rise • Alliance News • 05/14/2024 06:41:32 PM
- Celadon Pharmaceuticals PLC Final Results • RNS Regulatory News • 05/14/2024 06:00:12 AM
- Celadon raises GBP2 million, extends credit facility • Alliance News • 05/10/2024 05:57:23 PM
- Celadon Pharmaceuticals PLC Fundraise, RCF Extension, Termination of CLN & TVR • RNS Regulatory News • 05/10/2024 06:00:08 AM
- Celadon hails early results of chronic pain trial • Alliance News • 03/08/2024 08:04:45 PM
- Celadon Pharmaceuticals PLC Early Economic Analysis of Feasibility Study Data • RNS Non-Regulatory • 03/07/2024 07:00:13 AM
- Celadon announces start of cannabis supply for two UK companies • Alliance News • 12/14/2023 02:18:53 PM
- Celadon Pharmaceuticals PLC Product Supplied to First Two Sales Contracts • UK Regulatory • 12/14/2023 07:00:00 AM
- Celadon Pharma raises GBP2.0 million via placing • Alliance News • 12/12/2023 05:40:04 PM
- Celadon Pharmaceuticals PLC Fundraise, Update on Future CLN Financing & TVR • UK Regulatory • 12/12/2023 02:00:00 PM
- Celadon shares rise on supply contract worth up to GBP26 million • Alliance News • 11/16/2023 11:45:35 AM
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM